Healthcare provider profile · identity verified

Azeb Zeleke

Nurse Practitioner · SEATTLE, WA · NPI 1073135661

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1036	128
Trazodone Hcl	Trazodone Hcl	572	72
Amlodipine Besylate	Amlodipine Besylate	515	70
Lisinopril	Lisinopril	409	49
Gabapentin	Gabapentin	392	51
Levothyroxine Sodium	Levothyroxine Sodium	382	42
Pantoprazole Sodium	Pantoprazole Sodium	323	36
Sertraline Hcl	Sertraline Hcl	305	38
Omeprazole	Omeprazole	286	42
Metformin Hcl	Metformin Hcl	282	39
Tamsulosin Hcl	Tamsulosin Hcl	273	32
Donepezil Hcl	Donepezil Hcl	256	35
Metoprolol Succinate	Metoprolol Succinate	242	35
Quetiapine Fumarate	Quetiapine Fumarate	242	34
Losartan Potassium	Losartan Potassium	236	35
Furosemide	Furosemide	199	34
Famotidine	Famotidine	187	35
Potassium Chloride	Potassium Chloride	185	28
Mirtazapine	Mirtazapine	179	21
Metoprolol Tartrate	Metoprolol Tartrate	168	29
Carvedilol	Carvedilol	165	21
Alcohol Prep Pads	Alcohol Antiseptic Pads	150	27
Eliquis	Apixaban	142	18
Clotrimazole	Clotrimazole	127	27
Hydrochlorothiazide	Hydrochlorothiazide	117	20
Xarelto	Rivaroxaban	114	19
Clopidogrel	Clopidogrel Bisulfate	111	17
Baclofen	Baclofen	109	12
Citalopram Hbr	Citalopram Hydrobromide	108	14
Memantine Hcl	Memantine Hcl	105	15
Risperidone	Risperidone	105	13
Olanzapine	Olanzapine	104	12
Fluticasone Propionate	Fluticasone Propionate	102	23
Metformin Hcl Er	Metformin Hcl	102	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	101	23
Divalproex Sodium	Divalproex Sodium	96	suppressed
Ketoconazole	Ketoconazole	91	21
Oxycodone Hcl	Oxycodone Hcl	87	25
Levetiracetam	Levetiracetam	85	suppressed
Duloxetine Hcl	Duloxetine Hcl	77	13
Lamotrigine	Lamotrigine	76	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	75	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	74	13
Allopurinol	Allopurinol	71	11
Escitalopram Oxalate	Escitalopram Oxalate	70	11
Albuterol Sulfate Hfa	Albuterol Sulfate	67	31
Buspirone Hcl	Buspirone Hcl	67	suppressed
Diclofenac Sodium	Diclofenac Sodium	65	21
Lorazepam	Lorazepam	64	12
Finasteride	Finasteride	57	suppressed
Nystatin	Nystatin	54	17
Latanoprost	Latanoprost	53	suppressed
Propranolol Hcl	Propranolol Hcl	53	suppressed
Pravastatin Sodium	Pravastatin Sodium	52	suppressed
Myrbetriq	Mirabegron	51	suppressed
Torsemide	Torsemide	51	suppressed
Ammonium Lactate	Ammonium Lactate	50	17
Hydralazine Hcl	Hydralazine Hcl	49	11
Alendronate Sodium	Alendronate Sodium	47	suppressed
Nyamyc	Nystatin	45	16
Incruse Ellipta	Umeclidinium Bromide	44	suppressed
Loperamide	Loperamide Hcl	43	suppressed
Simvastatin	Simvastatin	43	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	42	suppressed
Tramadol Hcl	Tramadol Hcl	42	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	41	suppressed
Montelukast Sodium	Montelukast Sodium	40	suppressed
Prazosin Hcl	Prazosin Hcl	39	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	38	suppressed
Zonisamide	Zonisamide	38	suppressed
Jardiance	Empagliflozin	36	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Spiriva Handihaler	Tiotropium Bromide	33	suppressed
Namzaric	Memantine Hcl/Donepezil Hcl	32	suppressed
Pregabalin	Pregabalin	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	suppressed
Glipizide	Glipizide	30	suppressed
Vascepa	Icosapent Ethyl	30	suppressed
Lovastatin	Lovastatin	29	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Memantine Hcl Er	Memantine Hcl	27	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	27	suppressed
Arnuity Ellipta	Fluticasone Furoate	26	suppressed
Divalproex Sodium Er	Divalproex Sodium	26	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	26	suppressed
Prednisone	Prednisone	26	suppressed
Benztropine Mesylate	Benztropine Mesylate	25	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	25	suppressed
Methocarbamol	Methocarbamol	25	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	23	suppressed
Glimepiride	Glimepiride	23	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	23	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	suppressed
Amantadine	Amantadine Hcl	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Lactulose	Lactulose	20	suppressed
Olanzapine Odt	Olanzapine	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Acetic Acid	Acetic Acid	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Lacosamide	Lacosamide	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	12
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	17	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Digoxin	Digoxin	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Sucralfate	Sucralfate	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	16	suppressed
Linzess	Linaclotide	16	suppressed
Unifine Pentips	Pen Needle, Diabetic	16	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Glycopyrrolate	Glycopyrrolate	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	13
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Ramelteon	Ramelteon	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Diazepam	Diazepam	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	12
Azithromycin	Azithromycin	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Cefadroxil	Cefadroxil	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Metoprolol-Hydrochlorothiazide	Metoprolol/Hydrochlorothiazide	13	suppressed
Selenium Sulfide	Selenium Sulfide	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Trospium Chloride	Trospium Chloride	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Acarbose	Acarbose	12	suppressed
Pulmicort Flexhaler	Budesonide	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Minocycline Hcl	Minocycline Hcl	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error